NovoCure NVCR Other payables, lease liabilities and accrued expenses
Other payables, lease liabilities and accrued expenses at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept nvcr:OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's other payables, lease liabilities and accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's other payables, lease liabilities and accrued expenses?
- NovoCure (NVCR) reported other payables, lease liabilities and accrued expenses of $90.34M in Q1 2026.
- How has NovoCure's other payables, lease liabilities and accrued expenses changed year-over-year?
- NovoCure's other payables, lease liabilities and accrued expenses increased by 1.2% year-over-year, from $89.25M to $90.34M.
- What is the long-term trend for NovoCure's other payables, lease liabilities and accrued expenses?
- Over 5 years (2020 to 2025), NovoCure's other payables, lease liabilities and accrued expenses has grown at a 11.0% compound annual growth rate (CAGR), from $59.97M to $101M.
- What does other payables, lease liabilities and accrued expenses mean?
- This captures miscellaneous short-term obligations including operational lease commitments and various accrued expenses not categorized as trade payables. It provides insight into the company's near-term cash outflow requirements related to ongoing business operations. High levels of these liabilities relative to cash flow may indicate pressure on working capital.